| Patient features may have been present in the past or at present. | ||
|---|---|---|
|  | ||
| Clinical case presentation and progress (include disease duration): 60 year old Caucasian female referred with anti-centromere antibody | ||
| Clinical features | ||
|  | ||
| □ Yes | ⊠ No | Skin thickening | 
| Describe location, extent, progression: | ||
|  | ||
| □ Yes | ⊠ No | Abnormal nailfold capillaries consistent with scleroderma | 
| ⊠ Yes | □ No | Calcinosis | 
| □ Yes | ⊠ No | Digital pulp loss or acro-osteolysis | 
| □ Yes | ⊠ No | Dysphagia for solids | 
| □ Yes | ⊠ No | Esophageal dilation | 
| □ Yes | ⊠ No | Finger flexion contracture | 
| □ Yes | ⊠ No | Finger tip ulcers or pitting scars | 
| ⊠ Yes | □ No | Puffy fingers | 
| □ Yes | ⊠ No | Interstitial lung disease or pulmonary fibrosis | 
| □ Yes | ⊠ No | Pulmonary arterial hypertension | 
| ⊠ Yes | □ No | Gastro-esophageal reflux disease | 
| □ Yes | ⊠ No | Raynaud’s phenomenon | 
| □ Yes | ⊠ No | Renal crisis | 
| □ Yes | ⊠ No | Telangiectasias | 
| □ Yes | ⊠ No | Tendon or bursal friction rubs | 
|  | ||
| Laboratory features | ||
|  | ||
| ⊠ Positive | □ Negative | Antinuclear antibody | 
| ⊠ Positive | □ Negative | Anti-centromere antibody | 
| □ Positive | ⊠ Negative | Anti-topoisomerase-I antibody | 
| □ Positive | ⊠ Negative | Anti-PM-Scl antibody | 
| □ Positive | ⊠ Negative | Anti-RNA polymerase III antibody | 
|  | ||
| Investigations | ||
|  | ||
| □ Yes | ⊠ No | DLCO < 80% predicted | 
| □ Yes | ⊠ No | FVC < 80% predicted | 
|  | ||
| Any other information which may be relevant to the probability this patient has Systemic Sclerosis: | ||